✦ LIBER ✦

Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer

✍ Scribed by D. A. L. Morgan

Publisher: Springer
Year: 1986
Tongue: English
Weight: 134 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00262290

No coin nor oath required. For personal study only.

✦ Synopsis

Eighteen patients suffering from small-cell lung cancer, all with measurable lesions, were treated with vindesine (3 mg/m2 i.v. on days 1 and 8 of a 21-day cycle). Partial responses (PR) were seen in six patients (three of whom had been previously heavily treated). Most patients tolerated the drug extremely well, an important consideration when expected cure rates are very poor.

📜 SIMILAR VOLUMES

Vindesine and high-dose cisplatin in the

Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer

✍ Fuks, Joachim Z. ;Patel, Halesh ;van Echo, David A. ;Hornedo, Javier ;Aisner, Jo 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Therapeutic efficacy and pharmacokinetic

Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma

✍ Joachim Z. Fuks; Merrill J. Egorin; Joseph Aisner; David A. Echo; Stanley Ostrow 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 480 KB

Twenty-nine patients with non-small cell lung cancer refractory to prior therapy were treated with either vindesine (VDS) alone (3 mg/m2 every week) or the combination of VDS plus cisplatin (DDP) (100 mg/m2 every 28 days). Serial blood and urine samples were collected to assess the pharmacokinetics

Combination of nedaplatin and vindesine

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer

✍ Nagio Takigawa; Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabat 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 110 KB

Role of vindesine in induction chemother

Role of vindesine in induction chemotherapy in locally-advanced non-small-cell lung cancer

✍ Jürgen R. Fischer; Peter Drings 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 341 KB

Cisplatin, vindesine and bleomycin (CVB)

Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer

✍ Loretta M. Itri; Richard J. Gralla; David P. Kelsen; Robert A. Chapman; Ephraim 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Treatment of small-cell lung cancer in e

Treatment of small-cell lung cancer in elderly patients

✍ Athanasios G. Pallis; Frances A. Shepherd; Denis Lacombe; Cesare Gridelli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views